In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,749	192 Pages	360iResearch	January, 2024	IRE18444777

Best Price Guarantee
Price	from $4,749
Length	192 Pages
Publisher	360iResearch
Published Date	January, 2024
SKU	IRE18444777

In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication - Global Forecast 2024-2030

The In Vivo CRO Market size was estimated at USD 4.46 billion in 2023 and expected to reach USD 4.87 billion in 2024, at a CAGR 9.75% to reach USD 8.56 billion by 2030.

Global In Vivo CRO Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In Vivo CRO Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In Vivo CRO Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In Vivo CRO Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories, Crown Bioscience, Inc., Eurofins Scientific SE, Evotec SE, ICON Plc, Labcorp Drug Development, Medpace, Inc., MI Bioresearch, Inc., Parexel International Corporation, Pharmacology Discovery Services, PPD Inc., Syneos Health, Syngene International Limited, Taconic Biosciences, Inc., and WuXi AppTec, Inc..

Market Segmentation & Coverage

This research report categorizes the In Vivo CRO Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Non-Rodent

Rodent
Mice

Rats

GLP Type
GLP Toxicology
In House

Outsourcing

Non-GLP
In House

Outsourcing

Indication
Autoimmune/inflammation conditions
Irritable Bowel Syndrome

Multiple Sclerosis

Osteoarthritis

Rheumatoid Arthritis

Blood Cancer

CNS conditions
ALS

Epilepsy

Huntington’s Disease

Muscle Regeneration

Parkinson’s Disease

Stroke

Traumatic Brain Injury

Diabetes

Obesity

Oncology

Pain management
Acute Pain

Chronic Pain

Solid Tumor
Patient-derived Xenograft

Syngeneic Model

Xenograft

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In Vivo CRO Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In Vivo CRO Market?
3. What are the technology trends and regulatory frameworks in the In Vivo CRO Market?
4. What is the market share of the leading vendors in the In Vivo CRO Market?
5. Which modes and strategic moves are suitable for entering the In Vivo CRO Market?

Note: PDF & Excel + Online Access - 1 Year

1. Preface: 1.1. Objectives of the Study; 1.2. Market Segmentation & Coverage; 1.3. Years Considered for the Study; 1.4. Currency & Pricing; 1.5. Language; 1.6. Limitations; 1.7. Assumptions; 1.8. Stakeholders
2. Research Methodology: 2.1. Define: Research Objective; 2.2. Determine: Research Design; 2.3. Prepare: Research Instrument; 2.4. Collect: Data Source; 2.5. Analyze: Data Interpretation; 2.6. Formulate: Data Verification; 2.7. Publish: Research Report; 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview: 4.1. Introduction; 4.2. In Vivo CRO Market, by Region
5. Market Insights: 5.1. Market Dynamics; 5.1.1. Drivers; 5.1.1.1. Increasing usage of outsourcing services due to economic benefits; 5.1.1.2. Growing investments in the pharmaceutical research by public and private sectors; 5.1.1.3. Rising focus on the development of biosimilar medicines and drugs; 5.1.2. Restraints; 5.1.2.1. High cost associated with the clinical trial processes; 5.1.3. Opportunities; 5.1.3.1. Globalization of clinical trial processes; 5.1.3.2. Competitive landscape in the pharmaceutical sector with patent applications; 5.1.4. Challenges; 5.1.4.1. Issues related to quality control in In vivo CROs; 5.2. Market Segmentation Analysis; 5.3. Market Trend Analysis; 5.4. Cumulative Impact of High Inflation; 5.5. Porter’s Five Forces Analysis; 5.5.1. Threat of New Entrants; 5.5.2. Threat of Substitutes; 5.5.3. Bargaining Power of Customers; 5.5.4. Bargaining Power of Suppliers; 5.5.5. Industry Rivalry; 5.6. Value Chain & Critical Path Analysis; 5.7. Regulatory Framework
6. In Vivo CRO Market, by Type: 6.1. Introduction; 6.2. Non-Rodent; 6.3. Rodent; 6.4.1. Mice; 6.4.2. Rats
7. In Vivo CRO Market, by GLP Type: 7.1. Introduction; 7.2. GLP Toxicology; 7.3.1. In House; 7.3.2. Outsourcing; 7.3. Non-GLP; 7.4.1. In House; 7.4.2. Outsourcing
8. In Vivo CRO Market, by Indication: 8.1. Introduction; 8.2. Autoimmune/inflammation conditions; 8.3.1. Irritable Bowel Syndrome; 8.3.2. Multiple Sclerosis; 8.3.3. Osteoarthritis; 8.3.4. Rheumatoid Arthritis; 8.3. Blood Cancer; 8.4. CNS conditions; 8.5.1. ALS; 8.5.2. Epilepsy; 8.5.3. Huntington’s Disease; 8.5.4. Muscle Regeneration; 8.5.5. Parkinson’s Disease; 8.5.6. Stroke; 8.5.7. Traumatic Brain Injury; 8.5. Diabetes; 8.6. Obesity; 8.7. Oncology; 8.8. Pain management; 8.9.1. Acute Pain; 8.9.2. Chronic Pain; 8.9. Solid Tumor; 8.10.1. Patient-derived Xenograft; 8.10.2. Syngeneic Model; 8.10.3. Xenograft
9. Americas In Vivo CRO Market: 9.1. Introduction; 9.2. Argentina; 9.3. Brazil; 9.4. Canada; 9.5. Mexico; 9.6. United States
10. Asia-Pacific In Vivo CRO Market: 10.1. Introduction; 10.2. Australia; 10.3. China; 10.4. India; 10.5. Indonesia; 10.6. Japan; 10.7. Malaysia; 10.8. Philippines; 10.9. Singapore; 10.
10. South Korea: 10.
11. Taiwan: 10.
12. Thailand: 10.
13. Vietnam
11. Europe, Middle East & Africa In Vivo CRO Market: 11.1. Introduction; 11.2. Denmark; 11.3. Egypt; 11.4. Finland; 11.5. France; 11.6. Germany; 11.7. Israel; 11.8. Italy; 11.9. Netherlands; 11.
10. Nigeria: 11.
11. Norway: 11.
12. Poland: 11.
13. Qatar: 11.
14. Russia: 11.
15. Saudi Arabia: 11.
16. South Africa: 11.
17. Spain: 11.
18. Sweden: 11.
19. Switzerland: 11.
20. Turkey: 11.
21. United Arab Emirates: 11.
22. United Kingdom
12. Competitive Landscape: 12.1. FPNV Positioning Matrix; 12.2. Market Share Analysis, By Key Player; 12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio: 13.1. Key Company Profiles; 13.1.1. Charles River Laboratories; 13.1.2. Crown Bioscience, Inc.; 13.1.3. Eurofins Scientific SE; 13.1.4. Evotec SE; 13.1.5. ICON Plc; 13.1.6. Labcorp Drug Development; 13.1.7. Medpace, Inc.; 13.1.8. MI Bioresearch, Inc.; 13.1.9. Parexel International Corporation; 13.1.
10. Pharmacology Discovery Services: 13.1.
11. PPD Inc.: 13.1.
12. Syneos Health: 13.1.
13. Syngene International Limited: 13.1.
14. Taconic Biosciences, Inc.: 13.1.
15. WuXi AppTec, Inc.: 13.2. Key Product Portfolio
14. Appendix: 14.1. Discussion Guide; 14.2. License & Pricing; FIGURE 1. IN VIVO CRO MARKET RESEARCH PROCESS; FIGURE 2. IN VIVO CRO MARKET SIZE, 2023 VS 2030; FIGURE 3. IN VIVO CRO MARKET SIZE, 2018-2030 (USD MILLION); FIGURE 4. IN VIVO CRO MARKET SIZE, BY REGION, 2023 VS 2030 (%); FIGURE 5. IN VIVO CRO MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 6. IN VIVO CRO MARKET DYNAMICS; FIGURE 7. IN VIVO CRO MARKET SIZE, BY TYPE, 2023 VS 2030 (%); FIGURE 8. IN VIVO CRO MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 9. IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2023 VS 2030 (%); FIGURE 10. IN VIVO CRO MARKET SIZE, BY GLP TYPE, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 11. IN VIVO CRO MARKET SIZE, BY INDICATION, 2023 VS 2030 (%); FIGURE 12. IN VIVO CRO MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 13. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%); FIGURE 14. AMERICAS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 15. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2023 VS 2030 (%); FIGURE 16. UNITED STATES IN VIVO CRO MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 17. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%); FIGURE 18. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%); FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION); FIGURE 21. IN VIVO CRO MARKET, FPNV POSITIONING MATRIX, 2023; FIGURE 22. IN VIVO CRO MARKET SHARE, BY KEY PLAYER, 2023

In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2024-2032

April, 2024 | Published by: IMARC Services Pvt. Ltd. | USD $3,899
In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type (Rodent Based, Non-rodent Based), By Modality (Small Molecule, Large Molecule), By Indication, By GLP Type (Non GLP, GLP Toxicology), By Region, And Segment Forecasts, 2024 - 2030

January, 2024 | Published by: Grand View Research | USD $5,950
Global In Vivo CRO Market Size study, by Type (Rodent, Non-Rodent), By GLP Type (Non-GLP, GLP Toxicology), By Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, Others) and Regional Forecasts 2022-2028.

July, 2022 | Published by: Bizwit Research & Consulting | USD $4,950
In-Vivo CRO Market Size, Trends, Analysis, and Outlook By Model (Rodent Based, Non-Rodent Based), By Modality (Small Molecules, Large Molecules), By Indication (Oncology, CNS Conditions, Diabetes, Obesity, Pain Management, Autoimmune/inflammation conditions, Others), By GLP Type (GLP Toxicology, Non GLP), by Region, Country, Segment, and Companies, 2024-2030

March, 2024 | Published by: VPA Research | USD $3,980
In Vivo CRO Market - By Animal Model (Rodent-based, Non-rodent-based), Service (Bioanalysis & DMPK Studies, Toxicity Studies), Drug Type (Small Molecule, Large Molecule), Therapeutic Area (Oncology, Cardiology), End-use, Global Forecast (2024 - 2032)

April, 2024 | Published by: Global Market Insights | USD $4,850
Global In Vivo Toxicology Market - 2024-2031

February, 2024 | Published by: DataM Intelligence 4Market Research LLP | USD $4,350

PDF E-mail From Publisher:	$4,749
PDF E-mail From Publisher (2-5)Users License:	$5,749
Site License:	$6,749
Global Site License Fulfilled by Publisher:	$8,749

In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication - Global Forecast 2024-2030

In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication - Global Forecast 2024-2030

Research Assistance

Other tasks

In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication - Global Forecast 2024-2030

In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication - Global Forecast 2024-2030

In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2024-2032

In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type (Rodent Based, Non-rodent Based), By Modality (Small Molecule, Large Molecule), By Indication, By GLP Type (Non GLP, GLP Toxicology), By Region, And Segment Forecasts, 2024 - 2030

Global In Vivo CRO Market Size study, by Type (Rodent, Non-Rodent), By GLP Type (Non-GLP, GLP Toxicology), By Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, Others) and Regional Forecasts 2022-2028.

In Vivo CRO Market - By Animal Model (Rodent-based, Non-rodent-based), Service (Bioanalysis & DMPK Studies, Toxicity Studies), Drug Type (Small Molecule, Large Molecule), Therapeutic Area (Oncology, Cardiology), End-use, Global Forecast (2024 - 2032)

Global In Vivo Toxicology Market - 2024-2031

Research Assistance

Other tasks